增强CT与非小细胞肺癌临床病理特征及预后的关系

doi:10.7517/issn.1674-0475.200206

影像科学与光化学 ›› 2020, Vol. 38 ›› Issue (4): 734-738.DOI: 10.7517/issn.1674-0475.200206

增强CT与非小细胞肺癌临床病理特征及预后的关系

吴涛¹, 陈江²

1. 重庆市秀山土家族苗族自治县人民医院放射科, 重庆 409900;
2. 重庆市黔江区中医院放射科, 重庆 409000

收稿日期:2020-02-24 出版日期:2020-07-15 发布日期:2020-07-15

The Relationship between Enhanced CT and Clinicopathological Characteristics and Prognosis of Non-small Cell Lung Cancer

WU Tao¹, CHEN Jiang²

1. Department of Radiology, Chongqing Xiushan Tujia and Miao Autonomous County People's Hospital, Chongqing 409900, P. R. China;
2. Department of Radiology, Qianjiang District Chinese Medicine Hospital, Chongqing 409000, P. R. China

Received:2020-02-24 Online:2020-07-15 Published:2020-07-15

摘要/Abstract

摘要： 本研究分析增强CT参数和非小细胞肺癌临床病理特征、预后之间的关系，并探讨影响非小细胞肺癌预后的因素。结果发现，肿瘤大小、CT强化、淋巴结肿大数量和淋巴结大小与非小细胞肺癌的分化程度、TNM分期，以及淋巴结转移相关；肿瘤体积大、淋巴结肿大、肿瘤CT强化及淋巴结转移，与不良预后相关并是判断其预后的独立危险因素。表明增强CT参数与非小细胞肺癌患者临床病理特征相关，并可预测非小细胞肺癌患者的预后。

关键词: 增强CT, 非小细胞肺癌, 临床病理特征, 预后

Abstract: In this study,the relationship between enhanced CT parameters and clinicpathological characteristics of non-small cell lung cancer was analyzed,and the factors influencing the prognosis were discussed. The results showed that tumor size, CT enhancement, number of lymph node enlargement, and lymph node size were related to the degree of non-small cell lung cancer differentiation, TNM staging, and lymph node metastasis. The large tumor size, lymphadenopathy, tumor CT enhancement, and lymph node metastasis are associated with poor prognosis,and are independent risk factors for prognosis. It indicates that enhanced CT parameters are correlated with the clinicopathological characteristics of patients with non-small cell lung cancer and can predict the prognosis of patients with non-small cell lung cancer.

Key words: enhanced CT, non-small cell lung cancer, clinicopathological features, prognosis

吴涛, 陈江. 增强CT与非小细胞肺癌临床病理特征及预后的关系[J]. 影像科学与光化学, 2020, 38(4): 734-738.

WU Tao, CHEN Jiang. The Relationship between Enhanced CT and Clinicopathological Characteristics and Prognosis of Non-small Cell Lung Cancer[J]. Imaging Science and Photochemistry, 2020, 38(4): 734-738.

参考文献

[1] Heo S J, Jung I, Lee C K, et al. A randomized phase Ⅱ trial of ERCC1 and RRM1 mRNA expression-based chemotherapy versus docetaxel/carboplatin in advanced non-small cell lung cancer[J]. Cancer Chemotherapy Pharmacology, 2016, 77(3):539-548.
[2] Dela C C S, Tanoue L T, Matthay R A. Lung cancer:epidemiology, etiology, and prevention[J]. Clinic in Chest Medicine, 2011, 32(4):605-644.
[3] Tang S, Pan Y, Wang Y, et al. Genome-wide association study of survival in early-stage non-small cell lung cancer[J]. Annals Surgical Oncology, 2015, 22(2):630-635.
[4] Xu Y H, Lu S. A meta-analysis of STAT3 and phospho-STAT3 expression and survival of patients with nonsmall-cell lung cancer[J]. European Journal of Surgical Oncology, 2014, 40(3):311-317.
[5] Yang M, Cao H, Guo X, et al. The number of resected lymph nodes (nLNs) combined with tumor size as a prognostic factor in patients with pathologic N0 and Nx non-small cell lung cancer[J]. PLoS One, 2013, 8(9):e73220.
[6] Nwogu CE, Groman A, Fahey D, et al. Number of lymph nodes and metastatic lymph node ratio are associated with survival in lung cancer[J]. The Annals of Thoracic Surgery, 2012, 93(5):1614-1619.
[7] Ashraf H, Dirksen A, Loft A, et al. Combined use of positron emission tomography and volume doubling time in lung cancer screening with low-dose CT scanning[J]. Thorax, 2011, 66(4):315-319.
[8] Al-Kadi O S. Assessment of texture measures susceptibility to noise in conventional and contrast enhanced computed tomography lung tumour images[J]. Computerized Medical Imaging and Graphics, 2010, 34(6):494-503.
[9] Pfluger T, Melzer H I, Schneider V, et al. PET/CT in malignant melanoma:contrast-enhanced CT versus plain low-dose CT[J]. European Journal of Nuclear Medicine and Molecular Imaging, 2011, 38(5):822-831.
[10] Lyv Y L, Yuan D M, Wang K, et al. Diagnostic performance of integrated positron emission tomography/computed tomography for mediastinal lymph node staging in non-small cell lung cancer:a bivariate systematic review and meta-analysis[J]. Journal of Thoracic Oncology, 2011, 6(8):1350-1358.
[11] Huellner M W, de Galiza Barbosa F, Husmann L, et al. TNM staging of non-small cell lung cancer:comparison of PET/MR and PET/CT[J]. Journal of Nuclear Medicine, 2016, 57(1):21-26.
[12] Baba T, Uramoto H, Kuwata T, et al. A study of surgically resected peripheral non-small cell lung cancer with a tumor diameter of 1.0 cm or less[J]. Scandinavian Journal of Surgery, 2011, 100(3):153-158.
[13] Donnem T, Hald S M, Paulsen E E, et al. Stromal CD8+ T-cell density-a promising supplement to TNM staging in non-small cell lung cancer[J]. Clinical Cancer Research, 2015, 21(11):2635-2643.
[14] Shien K, Toyooka S, Soh J, et al. Clinicopathological characteristics and lymph node metastasis pathway of non-small-cell lung cancer located in the left lingular division[J]. Interactive Cardiovascular and Thoracic Surgery, 2015, 20(6):791-796.
[15] Liu X H, Liu Z L, Sun M, et al. The long non-coding RNA HOTAIR indicates a poor prognosis and promotes metastasis in non-small cell lung cancer[J]. BMC Cancer, 2013, 13:464.
[16] Tsutani Y, Miyata Y, Nakayama H, et al. Appropriate sublobar resection choice for ground glass opacitydominant clinical stage IA lung adenocarcinoma:wedge resection or segmentectomy[J]. Chest, 2014, 145(1):66-71.
[17] Stojiljkovic D, Santrac N, Stojiljkovic T, et al. Correlation of tumor size as independent factor and disease stage with local recurrence of non-small cell lung carcinoma and its operability[J]. Journal of BUON, 2015, 20(1):166-172.
[18] Kang S, Kim Y S, Choi H J, et al. Additional value of combined evaluation of tumor size with lymph node size in the detection of lymph node metastases in earlystage cervical cancer patients[J]. Journal of Computer Assisted Tomography, 2013, 37(4):572-576.
[19] Osarogiagbon R U, Eke R, Sareen S, et al. The impact of a novel lung gross dissection protocol on intrapulmonary lymph node retrieval from lung cancer resection specimens[J]. Annals of Diagnostic Pathology, 2014, 18(4):220-226.
[20] Agarwal M, Brahmanday G, Chmielewski G W, et al. Age, tumor size, type of surgery, and gender predict survival in early stage (stage Ⅰ and Ⅱ) non-small cell lung cancer after surgical resection[J]. Lung Cancer, 2010, 68(3):398-402.
[21] Tateishi Y, Nakanishi Y, Taniguchi H, et al. Pathological prognostic factors predicting lymph node metastasis in submucosal invasive (T1) colorectal carcinoma[J]. Modern Pathology, 2010, 23(8):1068-1072.
[22] Dai C, Ren Y, Xie D, et al. Does lymph node metastasis have a negative prognostic impact in patients with NSCLC and M1a disease?[J].Journal of Thoracic Oncology, 2016, 11(10):1745-1754.

增强CT与非小细胞肺癌临床病理特征及预后的关系

The Relationship between Enhanced CT and Clinicopathological Characteristics and Prognosis of Non-small Cell Lung Cancer

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 4

编辑推荐

Metrics

本文评价

[1]	刘轼初, 谭学礼, 钟晓玲. 儿童及青少年甲状腺乳头状癌的术前超声声像及术后病理特征分析[J]. 影像科学与光化学, 2020, 38(5): 849-854.
[2]	李士英, 陈金叶. 超声造影联合增强CT诊断不典型肝血管平滑肌脂肪瘤的临床价值[J]. 影像科学与光化学, 2020, 38(3): 496-502.
[3]	郭小云, 王金桃. 急性脑梗死患者心电图特征与病情分型及其预后状况的关系[J]. 影像科学与光化学, 2020, 38(2): 286-290.
[4]	于春梅, 李春海, 杨茂生. 腹部CT对急性胰腺炎病况及预后的诊断价值[J]. 影像科学与光化学, 2019, 37(6): 618-623.